AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022
AbbVie today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium (MTIS) 2022, taking place in London from September 8-11.
Source: news-medical.net